tremelimumab Clinical Research Trials | TrialX

Loading...

Please select a valid location from the dropdown

Filter By

Clear all Advanced

Advanced Filters

Gender
Phase
Study Type
Sponsors
Accepts healthy volunteers
Online Trials
Age Group

Any (1)

Phase 1 (1)

Interventional (1)

The Netherlands Cancer Institute (1)

No (1)

No (1)

Adult (18+) (1)

I am/have/had

I am/have/hadcancer

I am/have/hadoophorectomy

I am/have/hadluteinizing hormone

I am/have/hadhysterectomy

I am/have/hadbilateral salpingectomy

I am/have/hadcombined modality therapy

I am/have/hadtubal ligation

I am/have/hadhormone levels

I am/have/hadnon-small cell lung cancer

I am/have/hadstage iii non-small cell lung cancer

I am/have/hadlung neoplasms

I am/have/hadebus

I am/have/hadbilateral oophorectomy

I am/have/hadpneumonectomy

I am/have/hadchemoradiotherapy

I am/have/hadcombination therapy

I am/have/hadmediastinoscopy

I am/have/hadlung neoplasm

I am/have/hadsecond primary cancer

I am/have/hadmale sterilization

added new label for I am/have/had

more

I am looking for

I am looking fortremelimumab

I am looking fordurvalumab

I am looking forluteinizing hormone

I am looking forfollicle stimulating hormone

I am looking forcisplatin

I am looking forpemetrexed

I am looking forcopper

I am looking forfollicle-stimulating hormone

added new label for I am looking for

more

Advanced Filters

Loading...

Found 1 clinical trials

We call this “infoimagery”. It is unique to every trial and is generated based on a trials specific data eg. therapeutic area, study type, phase etc. and the centerwatch system associates the information to a matching set of related symbols and icons.

What's this?

Phase 1
For Seniors
For adults
Recruiting in 10s
Interventional Study
all
Recruiting

Assess the Safety of Immunotherapy Induction With Tremelimumab and Durvalumab Prior to Chemoradiotherapy and/or Resection in the Treatment

A Phase Ib, Open-label, Single-center study to assess the safety of cancer-immunotherapy induction with Tremelimumab and Durvalumab prior to Chemoradiotherapy in the treatment of locally advanced NSCLC.

non-small cell lung cancer

tremelimumab

luteinizing hormone

oophorectomy

chemoradiotherapy

0 views
19 Feb, 2024

Congrats! You have your own personal workspace now.

Learn more

© Copyright TrialX 2024 All rights reserved.